sodium phosphate rectal (OTC)

Brand and Other Names:Fleet Enema, Pedia-Lax Enema, more...Fleet Enema Extra
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

Contains mixture of monobasic sodium phosphate and dibasic sodium phosphate

enema

  • (19g/7g)/118mL
  • (19g/7g)/197mL

Constipation & Bowel Cleansing

Indicated as laxative in the relief of occasional constipation and as part of a bowel cleansing regimen in preparing the colon for surgery, x-ray or endoscopic examination

1 bottle PR; not to exceed 1 administration/24 hr

Administration

Remove orange protective shield from enema tip before inserting; with steady pressure, gently insert enema tip into rectum with a slight side-to-side movement, with tip pointing toward navel

Insertion may be easier if person receiving enema bears down, as if having a bowel movement; this helps relax the muscles around the anus

Do not force enema tip into rectum as this can cause injury

Squeeze bottle until nearly all liquid is gone; it is not necessary to empty the bottle completely, as it contains more liquid than needed

Remove enema tip from rectum and maintain position until urge to evacuate is strong (usually 1-5 minutes)

Do not retain enema solution for more than 10 minutes

Enema should be at room temperature before use

Positions for using this enema

  • Left-side position: Lie on left side with knee bent, and arms resting comfortably
  • Knee-chest position: Kneel, and then lower head and chest forward until left side of face is resting on surface with left arm folded comfortably

Dosage Forms & Strengths

Contains mixture of monobasic sodium phosphate and dibasic sodium phosphate

enema

  • (9.5g/3.5g)/59mL

Constipation & Bowel Cleansing

Indicated as laxative in the relief of occasional constipation and as part of a bowel cleansing regimen in preparing the colon for surgery, x-ray or endoscopic examination

<2 years: Do not use

2-4 years: Administer one-half bottle PR of pediatric enema (ie, ~30 mL); prepare dose by unscrewing cap from bottle and removing 2 tablespoons of liquid (30 mL) with a measuring spoon, replace cap and administer remaining liquid

5-11 years: Administer 1 bottle PR of pediatric enema (ie, 59 mL)

12 years or older: Administer as in adults (adult enema)

Administration

Remove orange protective shield from enema tip before inserting; with steady pressure, gently insert enema tip into rectum with a slight side-to-side movement, with tip pointing toward navel

Insertion may be easier if person receiving enema bears down, as if having a bowel movement; this helps relax the muscles around the anus

Do not force enema tip into rectum as this can cause injury

Squeeze bottle until nearly all liquid is gone; it is not necessary to empty the bottle completely, as it contains more liquid than needed

Remove enema tip from rectum and maintain position until urge to evacuate is strong (usually 1-5 minutes)

Do not retain enema solution for more than 10 minutes

Enema should be at room temperature before use

Positions for using this enema

  • Left-side position: Lie on left side with knee bent, and arms resting comfortably
  • Knee-chest position: Kneel, and then lower head and chest forward until left side of face is resting on surface with left arm folded comfortably
Next:

Interactions

Interaction Checker

and sodium phosphate rectal

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 
            Previous
            Next:

            Adverse Effects

            Frequency Not Defined

            Hypersensitivity

            Pruritus

            Dehydration

            Hyperphosphatemia

            Hypocalcemia

            Hypokalemia

            Hypernatremia

            Metabolic acidosis

            Nausea

            Vomiting

            Abdominal pain

            Abdominal distension

            Diarrhea

            Gastrointestinal pain

            Chills

            Blistering

            Stinging

            Anal discomfort

            Proctalgia

            Previous
            Next:

            Warnings

            Contraindications

            Hypersensitivity

            Dehydration, renal impairment, heart failure, electrolyte abnormalities, use for bowel cleansing, bowel obstruction or pseudo, or perforation, gastric bypass or bariatric surgery, toxic megacolon, toxic colitis, or children <5 years

            Cautions

            Do not use laxatives when nausea, vomiting, or severe abdominal pain is present

            Caution with renal impairment or ascites; increases risk of sodium retention and edema; obtain baseline and postprocedure labs in patients with renal impairment; monitor closely to avoid hyperphosphatemia

            Caution in patients with a colostomy

            Caution in children aged 2-11 years or elderly patients with comorbidities

            Caution with pre-existing electrolyte disturbances or patients taking diuretics or other medications that may alter electrolytes

            Additional liquids by mouth are recommended to prevent dehydration; inadequate fluid intake may result in hypovolemia due to excessive fluid loss

            Exceeding daily dose, no return of enema solution, retention time >10 minutes, or failure to have a bowel movement within 30 minutes of enema use may lead to electrolyte disturbances, including hypernatremia, hyperphosphatemia, hypocalcemia, and hypokalemia

            Severe dehydration and electrolyte abnormalities associated with serious complications (eg, acute kidney injury, arrhythmias, and death) have occurred in adults and children who overdosed using oral or rectal over-the-counter (OTC) sodium phosphate solutions to treat constipation

            Use caution in unstable angina, cardiomyopathy, history of myocardial infarction arrhythmia, patients with or at risk for arrhythmias, including prolonged QT interval, cardiomyopathy, recent myocardial infarction; caution with other QT-prolonging drugs, consider pre-/postdose ECGs and lab tests in high-risk patients

            Correct dehydration prior to using in bowel preparations

            Use caution in patients with gastric retention or hypomotility, severe active ulcerative colitis or ileus, severe, chronic constipation

            Use caution in history of seizures, those at high risk of seizures or on seizure therapy; obtain baseline and postprocedure labs in high-risk patients

            Phosphate absorption may increase in patients with chronic inflammatory bowel disease; phosphate may induce colonic aphthous ulceration; consider this when interpreting colonoscopic findings in patients with inflammatory bowel disease

            Use caution in debilitated patients, including elderly patients; evaluate patients ability to hydrate properly if receiving bowel preparation

            Purgatives and laxatives can be potentially abused by bulimia nervosa patients

            Use caution in patients with impaired gag reflex and those prone to aspiration or regurgitation

            When used for bowel evacuation, medications may not be well absorbed due to intestinal peristalsis

            Exceeding recommended doses of OTC sodium phosphate preparation to treat constipation may potentially result in serious adverse effects; renal/cardiac adverse effects reported following severe dehydration and alterations in serum electrolytes, including sodium phosphate and calcium

            Previous
            Next:

            Pregnancy & Lactation

            Pregnancy Category: C

            Lactation: Unknown whether distributed in breast milk; caution because of risk for electrolyte disturbances or dehydration

            Pregnant or breastfeeding patients should seek advice of health professional before using OTC drugs

            Pregnancy Categories

            A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA: Information not available.

            Previous
            Next:

            Pharmacology

            Mechanism of Action

            Saline cathartic effect

            Previous
            Next:

            Images

            Previous
            Next:
            Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.